TRHC - Tabula Rasa HealthCare gains on report of potential sale of some businesses
Tabula Rasa HealthCare (NASDAQ:TRHC) rose 1.5% after a report that the company is said be exploring options for some of its businesses. TRHC is exploring options for its PrescribeWellness and medication therapy management units, according to an Axios Pro report. Talks are taking place with a group of strategic buyers that include PE-backed companies. Tabula Rasa (TRHC) last month singed a non-binding letter of intent to sell its DoseMeRx solution. Tabula Rasa acquired PrescribeWellness , a cloud-based patient relationship management solutions provider, in 2019, for an undisclosed amount. Axios Pro reported the purchase price as $150 million.
For further details see:
Tabula Rasa HealthCare gains on report of potential sale of some businesses